Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0042571 (vertigo)
 7,148 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The efficacy and acceptability of the adrenoceptive-blocking agent, Prazosin, as a male contraceptive pill were investigated in 10 healthy men who had been referred for sexual sterilization. Prazosin was administered by mouth twice a day at a dosage that was increased from 0.5 mg to a maximum of 5.0 mg for an average of 40 days (range 5-110 days). No significant differences were recorded in pretreatment and post-treatment values for semen volume or sperm concentration. Nor were there any significant changes in sperm penetration or motility as a result of treatment with Prazosin. No changes were noted in either blood chemistry or blood pressure. Postejaculation urine collected to detect possible signs of retrograde ejaculation contained no spermatozoa. 5 (50%) of volunteers complained of side effects, including minor vertigo, palpitation, and generalized discomfort. Overall these findings failed to confirm either the efficacy or the acceptability of Prazosin as a male contraceptive drug. Another adrenoceptive antagonist, phenoxybenzamine, has been shown to be an effective antifertility agent without significant side effects at doses as high as 30 mg/day. However, it should be noted that this agent is not chemically identical to Prazosin.
 ...
PMID:Prazosin, an adrenergic blocking agent inadequate as male contraceptive pill. 289 90